Latest Videos
Matthew Girgis, PharmD, PGY-2, discusses why it's advantageous to decrease patient exposure to vancomycin.
We asked providers in the field why they pursued a career in infectious disease.
The Congolese city is home to more than 2 million people and rests against the border of Rwanda, a nation that is potentially vulnerable to the spread of Ebola.
PrEP awareness among these MSM rose from 60% to 90% from 2014 to 2017, and PrEP use increased from 6% to 35%.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?